Royalty Pharma plc (NASDAQ: RPRX) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Royalty Pharma plc is $14.85B. A total of 1.35 million shares were traded on the day, compared to an average of 2.72M shares.

In the most recent transaction, RIGGS RORY B sold 235,200 shares of RPRX for 28.52 per share on Jan 02 ’24. After the transaction, the Director now owns 254,899 company shares. In a previous transaction on Jan 03 ’24, RIGGS RORY B sold 199,098 shares at 27.79 per share. RPRX shares that Director owns now total 55,801.

Among the insiders who sold shares, RIGGS RORY B disposed of 35,702 shares on Jan 04 ’24 at a per-share price of $27.55. This resulted in the Director holding 20,099 shares of RPRX after the transaction. In another insider transaction, Avara Management Ltd sold 65,803 shares at $28.04 per share on Dec 29 ’23. Company shares held by the 10% Owner now total 2,477,520.

Dividend

The dividend paying company demonstrates a positive outlook for investors and helps them generate immediate cash. Royalty Pharma plc pays an annual dividend of $0.84, resulting in a dividend yield of 3.33%, and it has a price to earnings (P/E) ratio of 9.87. RPRX’s most recent ex-dividend date was 3% when it declared a $0.21 quarterly dividend that was paid in cash on 11/15/2024. Previously, the company paid the dividend on 8/16/2024 with an ex-dividend date of 2.97%. The RPRX stock dividend was $0.21 per share in cash.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, RPRX has a high of $31.66 and a low of $24.05.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RPRX’s latest balance sheet shows that the firm has $2.80B in Cash & Short Term Investments as of fiscal 2021. There were $7.10B in debt and $171.25M in liabilities at the time. Its Book Value Per Share was $15.40, while its Total Shareholder’s Equity was $10.25B.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RPRX is Buy with a score of 4.57.

Most Popular

Related Posts